Dexcom (DXCM) Revenue Growth (3y) (2013 - 2026)
Dexcom (DXCM) Revenue Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.64 Bn | 176.34 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 129.04 Bn | 126.16 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 109.04 Bn | 99.82 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 48.67 Bn | 45.00 Bn | 1.29 Bn | 10.52% |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | 17.14% |
| 7 | GE HealthCare Technologies | 28.37 Bn | 26.08 Bn | 1.98 Bn | 2.92% |
| 8 | Smith & Nephew | 26.92 Bn | 26.34 Bn | - | - |
| 9 | Koninklijke Philips | 25.48 Bn | 22.36 Bn | 2.07 Bn | 0.73% |
| 10 | Steris | 21.54 Bn | 21.10 Bn | 697.10 Mn | 7.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.14% |
| Dec 31, 2025 | 15.61% |
| Sep 30, 2025 | 16.26% |
| Jun 30, 2025 | 18.45% |
| Mar 31, 2025 | 18.11% |
| Dec 31, 2024 | 16.83% |
| Sep 30, 2024 | 15.21% |
| Jun 30, 2024 | 19.06% |
| Mar 31, 2024 | 22.18% |
| Dec 31, 2023 | 22.06% |
| Sep 30, 2023 | 24.86% |
| Jun 30, 2023 | 24.47% |
| Mar 31, 2023 | 22.33% |
| Dec 31, 2022 | 20.77% |
| Sep 30, 2022 | 24.76% |
| Jun 30, 2022 | 27.44% |
| Mar 31, 2022 | 30.88% |
| Dec 31, 2021 | 27.36% |
| Sep 30, 2021 | 34.59% |
| Jun 30, 2021 | 34.88% |